# Curbline Properties Corp.: financial statements, quarterly

CURB · NYSE · CIK 2027317 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/curb.md) · [Financials](/companies/curb/financials.md) · [Filings](/companies/curb/filings.md) · [Insiders](/companies/curb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/curb/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [25.5 d](/filings/0001193125-26-043647.md) | [28.0](/filings/0000950170-25-058697.md) | [28.2](/filings/0000950170-25-099623.md) | [29.8](/filings/0001193125-25-254937.md) | [34.9 d](/filings/0001193125-26-043647.md) | [38.7](/filings/0001193125-26-188934.md) | [41.4](/filings/0001193125-26-322100.md) | [48.6](/filings/0001193125-26-428913.md) | [54.1 d](/filings/0001193125-26-043647.md) | [58.0](/filings/0001193125-26-188934.md) | [63.3](/filings/0001193125-26-322100.md) | [71.1](/filings/0001193125-26-428913.md) |
| Interest expense | $m | [0.4 d](/filings/0001193125-26-043647.md) | [0.3](/filings/0000950170-25-058697.md) | [0.2](/filings/0000950170-25-099623.md) | [0.0](/filings/0001193125-25-254937.md) | [0.5 d](/filings/0001193125-26-043647.md) | [0.6](/filings/0001193125-26-188934.md) | [1.8](/filings/0001193125-26-322100.md) | [4.0](/filings/0001193125-26-428913.md) | [5.8 d](/filings/0001193125-26-043647.md) | [7.9](/filings/0001193125-26-188934.md) | [8.4](/filings/0001193125-26-322100.md) | [8.5](/filings/0001193125-26-428913.md) |
| Income tax | $m | not reported | [0.0](/filings/0000950170-25-058697.md) | [0.0](/filings/0000950170-25-099623.md) | [0.0](/filings/0001193125-25-254937.md) | [0.0 d](/filings/0001193125-26-043647.md) | [0.1](/filings/0001193125-26-188934.md) | [0.1](/filings/0001193125-26-322100.md) | [0.0](/filings/0001193125-26-428913.md) | [0.1 d](/filings/0001193125-26-043647.md) | [0.1](/filings/0001193125-26-188934.md) | [0.1](/filings/0001193125-26-322100.md) | [(0.0)](/filings/0001193125-26-428913.md) |
| Net income | $m | [7.6 d](/filings/0001193125-26-043647.md) | [8.0](/filings/0000950170-25-099623.md) | [6.2](/filings/0000950170-25-099623.md) | [(15.4)](/filings/0001193125-25-254937.md) | [11.5](/filings/0000950170-25-024834.md) | [10.6](/filings/0001193125-26-322100.md) | [10.4](/filings/0001193125-26-322100.md) | [9.4](/filings/0001193125-26-428913.md) | [9.6 d](/filings/0001193125-26-043647.md) | [3.6](/filings/0001193125-26-322100.md) | [6.9](/filings/0001193125-26-322100.md) | [7.4](/filings/0001193125-26-428913.md) |
| Diluted EPS | $ per share | not reported | [0.08](/filings/0000950170-25-058697.md) | [0.06](/filings/0000950170-25-099623.md) | [(0.15)](/filings/0001193125-25-254937.md) | not reported | [0.10](/filings/0001193125-26-188934.md) | [0.10](/filings/0001193125-26-322100.md) | [0.09](/filings/0001193125-26-428913.md) | not reported | [0.03](/filings/0001193125-26-188934.md) | [0.06](/filings/0001193125-26-322100.md) | [0.06](/filings/0001193125-26-428913.md) |
| Basic EPS | $ per share | not reported | [0.08](/filings/0000950170-25-058697.md) | [0.06](/filings/0000950170-25-099623.md) | [(0.15)](/filings/0001193125-25-254937.md) | not reported | [0.10](/filings/0001193125-26-188934.md) | [0.10](/filings/0001193125-26-322100.md) | [0.09](/filings/0001193125-26-428913.md) | not reported | [0.03](/filings/0001193125-26-188934.md) | [0.06](/filings/0001193125-26-322100.md) | [0.06](/filings/0001193125-26-428913.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.6](/filings/0000950170-25-024834.md) | not reported | not reported | [2.5](/filings/0000950170-24-126295.md) | [626](/filings/0001193125-26-043647.md) | [594](/filings/0000950170-25-058697.md) | [430](/filings/0000950170-25-099623.md) | [430](/filings/0001193125-25-254937.md) | [290](/filings/0001193125-26-428913.md) | [306](/filings/0001193125-26-188934.md) | [155](/filings/0001193125-26-322100.md) | [123](/filings/0001193125-26-428913.md) |
| Total assets | $m | [922](/filings/0000950170-25-024834.md) | not reported | not reported | [1,167](/filings/0000950170-24-126295.md) | [2,033](/filings/0001193125-26-043647.md) | [2,121](/filings/0000950170-25-058697.md) | [2,134](/filings/0000950170-25-099623.md) | [2,445](/filings/0001193125-25-254937.md) | [2,470](/filings/0001193125-26-428913.md) | [2,621](/filings/0001193125-26-188934.md) | [2,841](/filings/0001193125-26-322100.md) | [3,033](/filings/0001193125-26-428913.md) |
| Total liabilities | $m | [59.0](/filings/0000950170-25-024834.md) | not reported | not reported | [50.0](/filings/0000950170-24-126295.md) | [90.5](/filings/0001193125-26-043647.md) | [185](/filings/0000950170-25-058697.md) | [205](/filings/0000950170-25-099623.md) | [522](/filings/0001193125-25-254937.md) | [556](/filings/0001193125-26-428913.md) | [722](/filings/0001193125-26-188934.md) | [749](/filings/0001193125-26-322100.md) | [760](/filings/0001193125-26-428913.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001193125-26-043647.md) | [99.0](/filings/0000950170-25-058697.md) | [99.1](/filings/0000950170-25-099623.md) | [396](/filings/0001193125-25-254937.md) | [423](/filings/0001193125-26-428913.md) | [596](/filings/0001193125-26-188934.md) | [596](/filings/0001193125-26-322100.md) | [596](/filings/0001193125-26-428913.md) |
| Shareholders' equity | $m | [863](/filings/0000950170-25-024834.md) | [879](/filings/0000950170-25-099623.md) | [966](/filings/0001193125-25-254937.md) | [1,117](/filings/0000950170-24-126295.md) | [1,942](/filings/0001193125-26-043647.md) | [1,934](/filings/0000950170-25-058697.md) | [1,926](/filings/0000950170-25-099623.md) | [1,920](/filings/0001193125-25-254937.md) | [1,909](/filings/0001193125-26-428913.md) | [1,894](/filings/0001193125-26-188934.md) | [2,086](/filings/0001193125-26-322100.md) | [2,266](/filings/0001193125-26-428913.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [10.3 d](/filings/0001193125-26-043647.md) | [15.5](/filings/0000950170-25-058697.md) | [16.9 d](/filings/0000950170-25-099623.md) | [(7.1) d](/filings/0001193125-25-254937.md) | [29.0 d](/filings/0001193125-26-043647.md) | [25.4](/filings/0001193125-26-188934.md) | [34.2 d](/filings/0001193125-26-322100.md) | [39.2 d](/filings/0001193125-26-428913.md) | [25.9 d](/filings/0001193125-26-043647.md) | [21.4](/filings/0001193125-26-188934.md) | [47.2 d](/filings/0001193125-26-322100.md) | [41.6 d](/filings/0001193125-26-428913.md) |
| Dividends paid | $m | not reported | [0.0](/filings/0000950170-25-058697.md) | [0.0 d](/filings/0000950170-25-099623.md) | [0.0 d](/filings/0001193125-25-254937.md) | [0.0 d](/filings/0001193125-26-043647.md) | [26.5](/filings/0001193125-26-188934.md) | [17.0 d](/filings/0001193125-26-322100.md) | [17.0 d](/filings/0001193125-26-428913.md) | [17.0 d](/filings/0001193125-26-043647.md) | [20.1](/filings/0001193125-26-188934.md) | [18.0 d](/filings/0001193125-26-322100.md) | [18.6 d](/filings/0001193125-26-428913.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [105](/filings/0000950170-25-058697.md) | [105](/filings/0000950170-25-099623.md) | [105](/filings/0001193125-25-254937.md) | [105](/filings/0001193125-26-188934.md) | [105](/filings/0001193125-26-322100.md) | [105](/filings/0001193125-26-428913.md) | [106](/filings/0001193125-26-188934.md) | [109](/filings/0001193125-26-322100.md) | [117](/filings/0001193125-26-428913.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 121,424,191 at 2026-10-20, from the cover of the [10-Q filed 2026-10-22](/filings/0001193125-26-428913.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.